PE Postmus
Impact in
- Oncology top 10%
- Lung Cancer Research Studies
- Peptidase Inhibition and Analysis
-
- Neuroendocrine Tumor Research Advances
Papers in
- Oncology 11
- Cancer Treatment and Pharmacology 5
- Lung Cancer Research Studies 5
- Peptidase Inhibition and Analysis 3
-
- Medical Imaging and Pathology Studies 2
- Lung Cancer Treatments and Mutations 2
- Co-authors
- Egbert F. Smit (4 shared papers)Bonne Biesma (2 shared papers)Elisabeth G.E. de Vries (6 shared papers)Harry J.M. Groen (2 shared papers)Eelco Fokkema (1 shared paper)NH Mulder (5 shared papers)D.Th. Sleijfer (3 shared papers)G. Sutedja (1 shared paper)
- Journals
- European Respiratory Journal (3 papers)British Journal of Cancer (3 papers)PubMed (10 papers)
- Partner nations
- NetherlandsItalyUnited States
In The Last Decade
PE Postmus
16 papers receiving 416 citations
Peers
Comparison fields: 5 of 49
- Oncology 329
- Epidemiology 218
- Neurology 75
- Pulmonary and Respiratory Medicine 99
- Molecular Biology 198
Countries citing papers authored by PE Postmus
This map shows the geographic impact of PE Postmus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by PE Postmus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites PE Postmus more than expected).
Fields of papers citing papers by PE Postmus
This network shows the impact of papers produced by PE Postmus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by PE Postmus. The network helps show where PE Postmus may publish in the future.
Co-authors
The 25 scholars most cited alongside PE Postmus, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 136 | |
| 2 | Characterization of three small cell lung cancer cell lines established from one patient during longitudinal follow-up. | 1988 | 74 |
| 3 | High-dose etoposide for refractory malignancies: a phase I study. | 1984 | 64 |
| 4 | 1992 | 41 | |
| 5 | 1996 | 29 | |
| 6 | Complications of treatment of small cell carcinoma of the lung. | 1983 | 21 |
| 7 | Results of the phase II EORTC study comparing paclitaxel/cisplatin with teniposide/cisplatin in patients with non-small cell lung cancer. EORTC Lung Cancer Cooperative Group. | 1996 | 20 |
| 8 | 1995 | 9 | |
| 9 | 1991 | 9 | |
| 10 | Quantitation of DNA topoisomerase II alpha messenger ribonucleic acid levels in a small cell lung cancer cell line and two drug resistant sublines using a polymerase chain reaction-aided transcript titration assay. | 1994 | 9 |
| 11 | Small-cell lung cancer: is there a standard therapy? | 1998 | 6 |
| 12 | Cisplatin/paclitaxel vs cisplatin/teniposide for advanced non-small-cell lung cancer. The EORTC Lung Cancer Cooperative Group. The European Organization for Research and Treatment of Cancer. | 1997 | 6 |
| 13 | High-dosage chemotherapy with autologous bone marrow reinfusion in the treatment of patients with solid tumours. The Groningen experience, 1981-1986. | 1986 | 4 |
| 14 | [Treatment of spontaneous pneumothorax: survey among Dutch pneumonologists]. | 1994 | 3 |
| 15 | 1991 | 2 | |
| 16 | Feasibility of high dose VP 16-213 as single agent or in combination with cyclophosphamide and autologous bone marrow transplantation (ABMT). | 1984 | 2 |
About PE Postmus
PE Postmus is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Epidemiology and Surgery, having authored 16 papers that have together received 435 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (5 papers), Lung Cancer Research Studies (5 papers), Neuroendocrine Tumor Research Advances (4 papers), Peptidase Inhibition and Analysis (3 papers), Airway Management and Intubation Techniques (2 papers), Medical Imaging and Pathology Studies (2 papers), Cancer therapeutics and mechanisms (2 papers) and Lung Cancer Treatments and Mutations (2 papers). The work is most often cited by research in Oncology (329 citations), Epidemiology (218 citations), Neurology (75 citations), Pulmonary and Respiratory Medicine (99 citations) and Molecular Biology (198 citations). PE Postmus has collaborated with scholars based in Netherlands, Italy and United States. Frequent co-authors include Egbert F. Smit, Bonne Biesma, Elisabeth G.E. de Vries, Harry J.M. Groen, Eelco Fokkema, NH Mulder, D.Th. Sleijfer, G. Sutedja, S Poppema and Bauke M. de Jong. Their work appears in journals such as European Respiratory Journal, British Journal of Cancer and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.